OpenURL Connection Search

Select item for more details and to access through your institution.

The PAC- SYM questionnaire for chronic constipation: defining the minimal important difference.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1103, doi. 10.1111/apt.14349
By:
- Yiannakou, Y.;
- Tack, J.;
- Piessevaux, H.;
- Dubois, D.;
- Quigley, E. M. M.;
- Ke, M. Y.;
- Da Silva, S.;
- Joseph, A.;
- Kerstens, R.
Publication type:
Article
Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1094, doi. 10.1111/apt.14345
By:
- Kumar, S.;
- Drake, M. T.;
- Schleck, C. D.;
- Johnson, M. L.;
- Alexander, J. A.;
- Katzka, D. A.;
- Iyer, P. G.
Publication type:
Article
Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease-Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1121, doi. 10.1111/apt.14360
By:
- Feathers, A.;
- Swaminath, A.;
- Ananthakrishnan, A. N.;
- Falzon, L.;
- Li Ferry, S.
Publication type:
Article
Systematic review with meta-analysis: rifaximin for the prophylaxis of spontaneous bacterial peritonitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1029, doi. 10.1111/apt.14361
By:
- Goel, A.;
- Rahim, U.;
- Nguyen, L. H.;
- Stave, C.;
- Nguyen, M. H.
Publication type:
Article
Letter: safety and efficacy of using statins in patients with cirrhosis-authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1125, doi. 10.1111/apt.14364
By:
- Bang, U. C.;
- Benfield, T.;
- Bendtsen, F.
Publication type:
Article
Editorial: the non-invasive diagnosis of atrophic gastritis.
Published in:
2017
By:
- Malfertheiner, P.
Publication type:
Editorial
Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1061, doi. 10.1111/apt.14342
By:
- Wong, C. R.;
- Njei, B.;
- Nguyen, M. H.;
- Nguyen, A.;
- Lim, J. K.
Publication type:
Article
Editorial: therapeutic drug monitoring for anti- TNF agents-has it all been said? Author's reply.
Published in:
2017
By:
- Nakase, H.
Publication type:
Editorial
Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1070, doi. 10.1111/apt.14367
By:
- Laurent, L.;
- Lemaitre, C.;
- Minello, A.;
- Plessier, A.;
- Lamblin, G.;
- Poujol‐Robert, A.;
- Gervais‐Hasenknopf, A.;
- Pariente, E.‐A.;
- Belenotti, P.;
- Mostefa‐Kara, N.;
- Sogni, P.;
- Legrand, M.;
- Cournac, J.‐M.;
- Tamion, F.;
- Savoye, G.;
- Bedossa, P.;
- Valla, D.‐C.;
- Vilgrain, V.;
- Goria, O.
Publication type:
Article
Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1037, doi. 10.1111/apt.14368
By:
- Mitrev, N.;
- Vande Casteele, N.;
- Seow, C. H.;
- Andrews, J. M.;
- Connor, S. J.;
- Moore, G. T.;
- Barclay, M.;
- Begun, J.;
- Bryant, R.;
- Chan, W.;
- Corte, C.;
- Ghaly, S.;
- Lemberg, D. A.;
- Kariyawasam, V.;
- Lewindon, P.;
- Martin, J.;
- Mountifield, R.;
- Radford‐Smith, G.;
- Slobodian, P.;
- Sparrow, M.
Publication type:
Article
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis-Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1118, doi. 10.1111/apt.14369
By:
- Zagari, R. M.;
- Greenwood, D. C.
Publication type:
Article
Declining trend in the incidence of biopsy-verified coeliac disease in the adult population of Finland, 2005-2014.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1085, doi. 10.1111/apt.14335
By:
- Virta, L. J.;
- Saarinen, M. M.;
- Kolho, K.‐L.
Publication type:
Article
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1117, doi. 10.1111/apt.14339
By:
- Graham, D. Y.
Publication type:
Article
Editorial: therapeutic drug monitoring for anti- TNF agents-has it all been said?
Published in:
2017
By:
- Domènech, E.;
- Cañete, F.;
- Mañosa, M.
Publication type:
Editorial
Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1119, doi. 10.1111/apt.14351
By:
- Logan, M.;
- Ijaz, U. Z.;
- Hansen, R.;
- Gerasimidis, K.;
- Russell, R. K.
Publication type:
Article
The negative impact of HBV/ HCV coinfection on cirrhosis and its consequences.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1054, doi. 10.1111/apt.14352
By:
- Pol, S.;
- Haour, G.;
- Fontaine, H.;
- Dorival, C.;
- Petrov‐Sanchez, V.;
- Bourliere, M.;
- Capeau, J.;
- Carrieri, P.;
- Larrey, D.;
- Larsen, C.;
- Marcellin, P.;
- Pawlostky, J.‐M.;
- Nahon, P.;
- Zoulim, F.;
- Cacoub, P.;
- Ledinghen, V.;
- Mathurin, P.;
- Negro, F.;
- Pageaux, G.‐P.;
- Yazdanpanah, Y.
Publication type:
Article
Letter: statins and cirrhosis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1123, doi. 10.1111/apt.14355
By:
- Athyros, V. G.;
- Katsiki, N.;
- Mikhailidis, D. P.
Publication type:
Article
Letter: safety and efficacy of using statins in patients with cirrhosis.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1124, doi. 10.1111/apt.14357
By:
- Zhao, J.;
- Tian, H.;
- Liang, C.
Publication type:
Article
Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1077, doi. 10.1111/apt.14371
By:
- Martineau, C.;
- Flourié, B.;
- Wils, P.;
- Vaysse, T.;
- Altwegg, R.;
- Buisson, A.;
- Amiot, A.;
- Pineton de Chambrun, G.;
- Abitbol, V.;
- Fumery, M.;
- Hébuterne, X.;
- Viennot, S.;
- Laharie, D.;
- Beaugerie, L.;
- Nancey, S.;
- Sokol, H.;
- Abitbol, Vered;
- Altwegg, Romain;
- Amiot, Aurélien;
- Beaugerie, Laurent
Publication type:
Article
Letter: rifaximin is more than helping hepatic encephalopathy-it also saves lives.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 11/12, p. 1122, doi. 10.1111/apt.14353
By:
- Wang, Y.‐L.;
- He, H.‐J.;
- Xiao, X.‐X.;
- Lin, Y.;
- Wang, B.‐Q.;
- Zhu, S.‐L.;
- Yang, G.‐S.;
- Huang, S.‐S.;
- Yang, Q.‐G.
Publication type:
Article
Editorial: ribavirin continues to play a role in treatment with direct-acting antivirals for hepatitis C virus-infected patients with decompensated cirrhosis.
Published in:
2017
By:
- Waldenström, J.;
- Lagging, M.
Publication type:
Editorial

Found: 21